{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:30:19Z","timestamp":1792636219907,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2017R1D1A1B03034469"],"award-info":[{"award-number":["2017R1D1A1B03034469"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contactlensjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contact Lens and Anterior Eye"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.clae.2018.06.002","type":"journal-article","created":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T19:57:35Z","timestamp":1530129455000},"page":"430-435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Long-term effects of intense pulsed light treatment on the ocular surface in patients with rosacea-associated meibomian gland dysfunction"],"prefix":"10.1016","volume":"41","author":[{"given":"Kyoung Yul","family":"Seo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Mo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Young","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Seung","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Won","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clae.2018.06.002_bib0005","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1067\/mjd.2002.120625","article-title":"Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea","volume":"46","author":"Wilkin","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clae.2018.06.002_bib0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1542-0124(12)70121-0","article-title":"Ocular rosacea","volume":"3","author":"Alvarenga","year":"2005","journal-title":"Ocul Surf"},{"key":"10.1016\/j.clae.2018.06.002_bib0015","first-page":"1863","article-title":"Ocular rosacea. Patient characteristics and follow-up","volume":"104","author":"Akpek","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clae.2018.06.002_bib0020","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archderm.1997.03890370055009","article-title":"Ocular rosacea:signs, symptoms, and tear studies before and after treatment with doxycycline","volume":"133","author":"Quarterman","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clae.2018.06.002_bib0025","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/00003226-200304000-00009","article-title":"The prevalence of ocular signs in acne rosacea:comparing patients from ophthalmology and dermatology clinics","volume":"22","author":"Ghanem","year":"2003","journal-title":"Cornea"},{"key":"10.1016\/j.clae.2018.06.002_bib0030","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s00417-005-0212-3","article-title":"Tear fluid levels of MMP-8 are elevated in ocular rosacea - treatment effect of oral doxycycline","volume":"244","author":"M\u00e4\u00e4tt\u00e4","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.clae.2018.06.002_bib0035","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/S0161-6420(97)30014-1","article-title":"Inflammatory cytokines in the tears of patients with ocular rosacea","volume":"104","author":"Barton","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clae.2018.06.002_bib0040","first-page":"2506","article-title":"Tear fluid gelatinase B activity correlates with IL-1\u03b1 concentration and fluorescein clearance in ocular rosacea","volume":"40","author":"Afonso","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clae.2018.06.002_bib0045","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/jidsymp.2011.7","article-title":"Clinical, cellular and molecular aspects in the pathophysiology of rosacea","volume":"15","author":"Steinhoff","year":"2011","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.clae.2018.06.002_bib0050","first-page":"16","article-title":"Advances in understanding and managing rosacea: part 1: connecting the dots between pathophysiological mechanisms and common clinical features of rosacea with emphasis on vascular changes and facial erythema","volume":"5","author":"Del Rosso","year":"2012","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.clae.2018.06.002_bib0055","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jdermsci.2014.04.002","article-title":"Vasoconstriction and anti-inflammatory properties of the selective a-adrenergic receptor agonist brimonidine","volume":"75","author":"Piwnica","year":"2014","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.clae.2018.06.002_bib0060","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1365-2133.2008.08702.x","article-title":"Treatment of rosacea with intense pulsed light: significant improvement and long-lasting results","volume":"159","author":"Papageorgiou","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clae.2018.06.002_bib0065","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3109\/14764172.2011.613480","article-title":"Intense pulsed light for the treatment of rosacea and telangiectasias","volume":"13","author":"Kassir","year":"2011","journal-title":"J Cosmet Laser Ther"},{"key":"10.1016\/j.clae.2018.06.002_bib0070","doi-asserted-by":"crossref","first-page":"491","DOI":"10.5021\/ad.2014.26.4.491","article-title":"The efficacy of intense pulsed light for treating erythematotelangiectatic Rosacea is related to severity and age","volume":"26","author":"Lim","year":"2014","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.clae.2018.06.002_bib0075","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/ICU.0000000000000166","article-title":"Intense pulsed light therapy for the treatment of evaporative dry eye disease","volume":"26","author":"Vora","year":"2015","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.clae.2018.06.002_bib0080","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1365-2133.2008.08702.x","article-title":"Treatment of rosacea with intense pulsed light: significant improvement and long-lasting results","volume":"159","author":"Papageorgiou","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clae.2018.06.002_bib0085","series-title":"Intense pulsed light: for treating dry eye, review of ophthalmology","author":"Kent","year":"2010"},{"key":"10.1016\/j.clae.2018.06.002_bib0090","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1089\/pho.2014.3819","article-title":"Intense pulsed light treatment for dry eye disease due to meibomian gland dysfunction; a 3-year retrospective study","volume":"33","author":"Toyos","year":"2015","journal-title":"Photomed Laser Surg"},{"key":"10.1016\/j.clae.2018.06.002_bib0095","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1167\/iovs.14-15764","article-title":"Prospective trial of intense pulsed light for the treatment of meibomian gland dysfunction","volume":"56","author":"Craig","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clae.2018.06.002_bib0100","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/ICO.0000000000000735","article-title":"Combination therapy of intense pulsed light therapy and meibomian gland expression (IPL\/MGX) can improve dry eye symptoms and meibomian gland function in patients with refractory dry eye: a retrospective analysis","volume":"35","author":"Vegunta","year":"2016","journal-title":"Cornea"},{"key":"10.1016\/j.clae.2018.06.002_bib0105","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2147\/OPTH.S130706","article-title":"Prospective evaluation of intense pulsed light and meibomian gland expression efficacy on relieving signs and symptoms of dry eye disease due to meibomian gland dysfunction","volume":"11","author":"Dell","year":"2017","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.clae.2018.06.002_bib0110","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1910694","article-title":"Evaluation of the safety and effectiveness of intense pulsed light in the treatment of meibomian gland dysfunction","volume":"2016","author":"Jiang","year":"2016","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.clae.2018.06.002_bib0115","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jcjo.2016.01.005","article-title":"Outcomes of intense pulsed light therapy for treatment of evaporative dry eye disease","volume":"51","author":"Gupta","year":"2016","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.clae.2018.06.002_bib0120","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ajo.2017.08.021","article-title":"Analysis of cytokine levels in tears and clinical correlations after intense pulsed light treating meibomian gland dysfunction","volume":"183","author":"Liu","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clae.2018.06.002_bib0125","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1167\/iovs.10-6997a","article-title":"The international workshop on meibomian gland dysfunction: executive summary","volume":"52","author":"Nichols","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clae.2018.06.002_bib0130","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ajo.2016.06.025","article-title":"Development of definitive and reliable grading scales for meibomian gland dysfunction","volume":"169","author":"Arita","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clae.2018.06.002_bib0135","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1177\/0300060513504701","article-title":"Noninvasive keratograph assessment of tear film break-up time and location in patients with age-related cataracts and dry eye syndrome","volume":"42","author":"Jiang","year":"2014","journal-title":"J Int Med Res"},{"key":"10.1016\/j.clae.2018.06.002_bib0140","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/ceo.12993","article-title":"Assessment of meibomian glands and tear film in post-refractive surgery patients","volume":"45","author":"Jung","year":"2017","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.clae.2018.06.002_bib0145","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.118.5.615","article-title":"Reliability and validity of the ocular surface disease index","volume":"118","author":"Schiffman","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clae.2018.06.002_bib0150","first-page":"221","article-title":"Report of the national eye institute\/industry workshop on clinical trials in dry eyes","volume":"21","author":"Lemp","year":"1995","journal-title":"CLAO J"},{"key":"10.1016\/j.clae.2018.06.002_bib0155","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.ajo.2014.02.036","article-title":"Evaluation of dry eye and meibomian gland dysfunction after cataract surgery","volume":"157","author":"Han","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clae.2018.06.002_bib0160","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.ajo.2012.06.009","article-title":"Minocycline controls clinical outcomes and inflammatory cytokines in moderate and severe meibomian gland dysfunction","volume":"154","author":"Lee","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clae.2018.06.002_bib0165","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/j.ophtha.2009.04.037","article-title":"Proposed diagnostic criteria for obstructive meibomian gland dysfunction","volume":"116","author":"Arita","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clae.2018.06.002_bib0170","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00003226-199801000-00007","article-title":"Evaluation of subjective assessments and objective diagnostic tests for diagnosing tear-film disorders known to cause ocular irritation","volume":"17","author":"Pflugfelder","year":"1998","journal-title":"Cornea"},{"key":"10.1016\/j.clae.2018.06.002_bib0175","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.ophtha.2007.06.031","article-title":"Noncontact infrared meibography to document age-related changes of the meibomian glands in a normal population","volume":"115","author":"Arita","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clae.2018.06.002_bib0180","first-page":"600","article-title":"Objective and quantitative improvement of rosacea-associated erythema after intense pulsed light treatment","volume":"29","author":"Mark","year":"2003","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clae.2018.06.002_bib0185","first-page":"43","article-title":"Standard management options for rosacea, part 1: overview and broad spectrum of care","volume":"84","author":"Odom","year":"2009","journal-title":"Cutis"}],"container-title":["Contact Lens and Anterior Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367048417304447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367048417304447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T01:13:53Z","timestamp":1761268433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1367048417304447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1367048417304447"],"URL":"https:\/\/doi.org\/10.1016\/j.clae.2018.06.002","relation":{},"ISSN":["1367-0484"],"issn-type":[{"value":"1367-0484","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term effects of intense pulsed light treatment on the ocular surface in patients with rosacea-associated meibomian gland dysfunction","name":"articletitle","label":"Article Title"},{"value":"Contact Lens and Anterior Eye","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clae.2018.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd on behalf of British Contact Lens Association.","name":"copyright","label":"Copyright"}]}}